Michigan-based startup HistoSonics raised $54 million in its Series C funding round to support the noninvasive Robotically Assisted Sonic Therapy (RAST) platform, an AI solution that combines advanced robotics and imaging to destroy unwanted tissue.

Google has opened its first African-based AI lab in Accra, Ghana, CNN reported April 15.

Researchers at the University of Washington have developed a method for streamlining electronic medical record (EMR) data entry using convolutional neural networks (CNNs) and transfer learning, according to a paper published April 12 in Artificial Intelligence in Medicine.

An AI agent developed at the Georgia Institute of Technology automatically generates natural language explanations in real-time to explain the motivations behind its actions, ideally allowing those who aren’t experts in the field to interact with AI tools more confidently.

As precision medicine transforms disease treatment into a patient-by-patient art and science, AI is poised to help quickly identify or even predict genetic mutations, pointing the way to highly targeted therapies.

Omega Medical Imaging’s FluoroShield gained FDA clearance this month, becoming the first AI-enabled radiation reduction technology to hit the market.

The majority of recent journal studies evaluating the performance of AI algorithms failed to adequately validate test results, according to a meta-analysis published in the Korean Journal of Radiology, meaning most of that research can only serve as proof-of-concept and might not translate into clinical performance.

The future direction of AI research and development will fall into the hands of just nine global companies—three from China and six from the U.S.—Forbes reported April 10.

AI is poised to make a sizable impact on healthcare this year, but we’ll likely see the greatest dent in the areas of medical imaging, diagnostics and suicide risk prediction, according to data presented at the Partners HealthCare World Medical Innovation Forum in Boston.

A rare and difficult-to-diagnose genetic condition that raises LDL (bad) cholesterol to dangerous levels is now vulnerable to an AI tool.